H1 antagonis Gen 2
Olopatadine adalah obat antihistamin yang digunakan untuk mengatasi gatal dan kemerahan
pada mata akibat alergi. Olopatadine tidak dianjurkan untuk pengobatan mata iritasi akibat
penggunaan lensa kontak.PasteTextHere
Efek Samping
Efek samping apa yang mungkin terjadi karena Olopatadine?
Hentikan penggunaan olopatadine segera apabila Anda mengalami kemerahan, bengkak,
perih, drainase, kerak atau iritasi lainnya saat menggunakan obat tetes mata.
Tidak semua orang mengalami efek samping berikut ini. Mungkin ada beberapa efek
samping yang tidak disebutkan di atas. Bila Anda memiliki kekhawatiran mengenai efek
samping tertentu, konsultasikanlah pada dokter atau apoteker Anda.
PHARMACOLOGY
Indication
Olopatadine is indicated for the symptomatic treatment of ocular itching
associated with allergic conjunctivitis as ophthalmic solution.7
Dosis
Informasi yang diberikan bukanlah pengganti dari nasihat medis. SELALU
konsultasikan pada dokter atau apoteker Anda sebelum memulai pengobatan.
Dosis Ketotifen
Dosis setiap orang berbeda dan umumnya ditentukan oleh umur dan respon tubuh
terhadap obat. Berikut ini adalah dosis umum penggunaan ketotifen:
Pusing
Sakit kepala
Mulut kering
Cystitis (peradangan kandung kemih)
Mengantuk
PHARMACOLOGY
Indication
Indicated as an add-on or prophylactic oral medication in the chronic
treatment of mild atopic asthmatic children. Also used as self-medication for
the temporary relief of itching of the eye due to allergic conjunctivitis
(ophthalmic).
Associated Conditions
Asthma, Allergic
Conjunctivitis, Seasonal Allergic
Pharmacodynamics
Ketotifen is a fast acting non-competitive histamine antagonist. It inhibits the
release of mediators from mast cells. It is a non-bronchodilator antiasthmatic
drug (when taken orally).
Mechanism of action
Ketotifen is a relatively selective, non-competitive histamine antagonist (H1-
receptor) and mast cell stabilizer. Ketotifen inhibits the release of mediators
from mast cells involved in hypersensitivity reactions. Decreased chemotaxis
and activation of eosinophils have also been demonstrated. Ketotifen also
inhibits cAMP phosphodiesterase. Properties of ketotifen which may
contribute to its antiallergic activity and its ability to affect the underlying
pathology of asthma include inhibition of the development of airway hyper-
reactivity associated with activation of platelets by PAF (Platelet Activating
Factor), inhibition of PAF-induced accumulation of eosinophils and platelets in
the airways, suppression of the priming of eosinophils by human recombinant
cytokines and antagonism of bronchoconstriction due to leukotrienes.
Ketotifen inhibits of the release of allergic mediators such as histamine,
leukotrienes C4 and D4(SRS-A) and PAF.